Navoban (Tropisetron, ICS 205-930) and Dexamethasone Combination in the Prevention of Vomiting for Patients Receiving Preconditioning High-dose Chemotherapy before Marrow Transplantation

Japanese Journal of Clinical Oncology

Volumn 28, Issue 2, 1998, Pages 129-133

  Yen, Chueh Chuan ^a   Hsieh, Ruey Kuen ^a,b   Chiou, Tzeon Jye ^a   Liu, Jin Hwang ^a   Fang, Frank S ^a   Wang, Wei Shu ^a   Tung, Shiao Lin ^a   Tzeng, Cheng Hwai ^a   Chen, Po Min ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Bone marrow transplantation; Dexamethasone; Serotonin antagonist; Vomiting

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BEAM PROTOCOL; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; INDOLE DERIVATIVE; MELPHALAN; PODOPHYLLOTOXIN; TROPISETRON;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; CHILD; CLINICAL TRIAL; DIZZINESS; DRUG COMBINATION; FEMALE; HEADACHE; HEARTBURN; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; VOMITING; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; BUSULFAN; CARMUSTINE; CHILD; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DIZZINESS; DRUG THERAPY, COMBINATION; FEMALE; HEADACHE; HEARTBURN; HUMANS; INDOLES; LEUKEMIA; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PODOPHYLLOTOXIN; TRANSPLANTATION CONDITIONING; VOMITING; WHOLE-BODY IRRADIATION;

EID: 0031990630     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.2.129     Document Type: Article

References (19)

1. Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis New Engl J Med 1993;329:1790-6.
2. Felling JH, Grochow LB, Folstein MF, Ettinger DS, Colvin M. The course of nausea and vomiting after high-dose cyclophosphamide. Cancer Treat Rep 1982;66:1487-93.
3. Kris MG, Tyson LB, Gralla RJ, Clark RA, Allen JC, Reilly LK. Extrapyramidal reactions with high dose metoclopramide [letter] New Engl J Med 1983;309:433-1.
4. Einhom LH, Nagy C, Werner K, Finn AL Ondansetron: a new antiemetic for patients receiving cisplatin chemotherapy. J Clin Oncol 1990;8:731-5
5. Hesketh PJ, Murphy WK, Lester EP, Gandara DR, Khojasteh A, Tapazoglou E, et al. GR 38032F (GR-C507175): a novel compound effective in the prevention of acute cisplatin-induced emesis J Clin Oncol 1989;7:700-5.
6. 3 receptor antagonist, in the prevention of radiation-induced emesis. Radiother Oncol 1992;23 131-2.
7. 3 receptor antagonist review of preclinical and clinical results with ICS 205-903. Cancer Treat Rev 1990;17:301-5.
8. Bregni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM Tropisetron plus halopendol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy Eur J Cancer 1991;27:561-5.
9. Roila F, Tonato M, Cognetti F, Cortesi E, Favalli G, Marangolo M, et al Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991;9:675-8.
10. Smyth JF, Coleman RE, Nicolson M, Gallmeier WM, Leonard RCF, Combleet MA, et al Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? BMJ 1991;303:1423-6.
11. Spitzer TR, Bryson JC, Cirenza E, Foellber R, Wallerstadt M, Stout C, et al. Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation J Clin Oncol 1994;12:2432-8.
12. Okamoto S, Takahashi S, Tanosaki R, Sakamaki H, Onozawa Y, Oh H, et al. Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study Bone Marrow Transplant 1996;17:679-83.
13. 3 antagonist. Bone Marrow Transplant 1991;7:431-3.
14. Schwella N, Konig V, Schwerdtfeger R, Schmidt-Wolf I, Schmid H, Riess H, et al Ondansetron for efficient emesis control during total body irradiation. Bone Marrow Transplant 1994;13:169-71.
15. Agura ED, Brown MC, Schaffer R, Donaldson G, Shen DD. Antiemetic efficacy and pharmacokinetics of intravenous ondansetron infusion during chemotherapy conditioning for bone marrow transplant. Bone Marrow Transplant 1995;16:213-22.
16. 3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation Bone Marrow Transplant 1991;7:439-41.
17. Prentice HG, Cunningham S, Gandhi L, Cunningham J, Collis C, Hamon MD Grasetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 1995,15:445-8.
18. Or R, Drakos P, Nagler A, Naparstek E, Kapelushnik J, Cass Y. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation. Support Care Cancer 1994;2:245-8.
19. Hulstaert F, Van Belle S, Bleigerg H, Canon JL, Dewitte M, Buyse M, et al. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting. J Clin Oncol 1994;12:2439-46.